In AD patients, cholinergic dysfunction is one of the primary causes of cognitive disorders, in which decreased activity of the enzyme choline acetyltransferase (ChAT) responsible for acetylcholine (ACh) synthesis in cholinergic neurons is observed [3,4]. The gene discussed is CHAT; the disease is cognitive disorder.